Muraoka, G.; Fujii, Y.; Liu, K.; Qiao, H.; Wang, D.; Ousaka, D.; Oozawa, S.; Kasahara, S.; Nishibori, M.
Anti-HMGB1 Antibody Therapy Ameliorates Spinal Cord Ischemia–Reperfusion Injury in Rabbits. Int. J. Mol. Sci. 2025, 26, 8643.
https://doi.org/10.3390/ijms26178643
AMA Style
Muraoka G, Fujii Y, Liu K, Qiao H, Wang D, Ousaka D, Oozawa S, Kasahara S, Nishibori M.
Anti-HMGB1 Antibody Therapy Ameliorates Spinal Cord Ischemia–Reperfusion Injury in Rabbits. International Journal of Molecular Sciences. 2025; 26(17):8643.
https://doi.org/10.3390/ijms26178643
Chicago/Turabian Style
Muraoka, Genya, Yasuhiro Fujii, Keyue Liu, Handong Qiao, Dengli Wang, Daiki Ousaka, Susumu Oozawa, Shingo Kasahara, and Masahiro Nishibori.
2025. "Anti-HMGB1 Antibody Therapy Ameliorates Spinal Cord Ischemia–Reperfusion Injury in Rabbits" International Journal of Molecular Sciences 26, no. 17: 8643.
https://doi.org/10.3390/ijms26178643
APA Style
Muraoka, G., Fujii, Y., Liu, K., Qiao, H., Wang, D., Ousaka, D., Oozawa, S., Kasahara, S., & Nishibori, M.
(2025). Anti-HMGB1 Antibody Therapy Ameliorates Spinal Cord Ischemia–Reperfusion Injury in Rabbits. International Journal of Molecular Sciences, 26(17), 8643.
https://doi.org/10.3390/ijms26178643